1-20 of 32
Piotr Smolewski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health-Related Quality of Life (HRQoL) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) in the Phase III POLARIX Study

Jonathan W. Friedberg, Carrie A. Thompson, Marek Trněný, Franck Morschhauser, Gilles Salles, Patrick M. Reagan, Mark Hertzberg, Piotr Smolewski, Huilai Zhang, Catherine Thieblemont, Bei Hu, Gustavo Fonseca, Won-Seog Kim, Maurizio Martelli, Amitkumar Mehta, Avrita Campinha-Bacote, Mark Yan, Jamie Hirata, Matthew Sugidono, Calvin Lee, Jeff P. Sharman
Journal: Blood
Blood (2022) 140 (Supplement 1): 6623–6626.
https://doi.org/10.1182/blood-2022-157761
Published: 2022
Journal Articles

Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study

David J. Straus, MD, Monika Dlugosz-Danecka, MD PhD, Joseph M. Connors, MD, Árpád Illés, MD PhD, Marco Picardi, MD, Ewa Lech-Marańda, MD PhD, Tatyana Feldman, Piotr Smolewski, MD PhD, Kerry J. Savage, MDMSc, Nancy L. Bartlett, MD, Jan Walewski, MD, Radhakrishnan Ramchandren, MD, Pier Luigi Zinzani, MD, Martin Hutchings, MD PhD, Javier Munoz, MD, Won Seog Kim, MD PhD, Ranjana Advani, MD, Stephen M. Ansell, MD PhD, Anas Younes, Andrea Gallamini, Rachael Liu, PhD, Meredith Little, MPH, Keenan Fenton, Michelle A. Fanale, MD, John A. Radford, MD FMedSci
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–28.
https://doi.org/10.1182/blood-2020-137089
Published: 2020
Journal Articles

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

Clinical Trials & Observations
David J. Straus, Monika Długosz-Danecka, Sergey Alekseev, Árpád Illés, Marco Picardi, Ewa Lech-Maranda, Tatyana Feldman, Piotr Smolewski, Kerry J. Savage, Nancy L. Bartlett, Jan Walewski, Radhakrishnan Ramchandren, Pier Luigi Zinzani, Martin Hutchings, Joseph M. Connors, John Radford, Javier Munoz, Won Seog Kim, Ranjana Advani, Stephen M. Ansell, Anas Younes, Harry Miao, Rachael Liu, Keenan Fenton, Andres Forero-Torres, Andrea Gallamini
Journal: Blood
Blood (2020) 135 (10): 735–742.
https://doi.org/10.1182/blood.2019003127
Published: 2020
Includes: Supplemental data
Journal Articles

Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 Study

Nancy L. Bartlett, MD, David J. Straus, MD, Monika Dlugosz-Danecka, MD PhD, Sergey Alekseev, PhD, Arpad Illes, MD, Ewa Lech-Maranda, MD PhD, Tatyana A. Feldman, MD, Piotr Smolewski, MD PhD, Kerry J Savage, BSc, MD MSc, Jan Walewski, MD PhD, Radhakrishnan Ramchandren, MD, Pier Luigi Zinzani, MD PhD, Martin Hutchings, MD PhD, Joseph M. Connors, MD, John Radford, Javier Munoz, MD MS, FACP, Won-Seog Kim, MD PhD, Ranjana H Advani, MD, Stephen M Ansell, MD PhD, Anas Younes, MD, Andrea Gallamini, MD, Harry Miao, MD, Rachael Liu, PhD, Keenan Fenton, Andres Forero-Torres, MD, Marco Picardi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4026.
https://doi.org/10.1182/blood-2019-124116
Published: 2019
Journal Articles

Brentuximab Vedotin Alone and in Combination with Bendamustine As Salvage Therapy for Primary Refractory or Relapsed Hodgkin Lymphoma: Multicentre Experience of the Polish Lymphoma Research Group (PLRG)

Anna Czyz, MD PhD, Anna Lojko-Dankowska, Monika Joks, MD, Mieczyslaw Komarnicki, MD PhD, Monika Dlugosz-Danecka, MD PhD, Wojciech Jurczak, Justyna Rybka, MD PhD, Tomasz Wrobel, MD PhD, Ewa Paszkiewicz, Jan Walewski, MD, Dorota Hawrylecka, Joanna Drozd-Sokolowska, MD PhD, Edyta Subocz, Szymanska Agata, Magdalena Witkowska, Piotr Smolewski, MD PhD, Agnieszka Kolkowska, Ewa Lech Maranda, Wanda Knopinska-Posluszny, Sebastian Giebel, Jan Zaucha, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5375.
https://doi.org/10.1182/blood-2018-99-116610
Published: 2018
Journal Articles

Brentuximab Vedotin Plus Doxorubicin, Vinblastine, Dacarbazine (A+AVD) As Frontline Therapy Demonstrates Superior Modified Progression-Free Survival Versus ABVD in Patients with Previously Untreated Stage III or IV Hodgkin Lymphoma (HL): The Phase 3 Echelon-1 Study

Joseph M Connors, MD, Wojciech Jurczak, PhDMD, David J. Straus, MD, Stephen M Ansell, MD PhD, Won Seog Kim, MD, Ph. D., Andrea Gallamini, MD, Anas Younes, MD, Sergei Alekseev, PhD, Arpad Illes, MD, Marco Picardi, Ewa Lech-Maranda, MDPhD, Yasuhiro Oki, MD, Tatyana A Feldman, MD, Piotr Smolewski, MD PhD, Kerry J Savage, BSc, MD MSc, Nancy L. Bartlett, MD, Jan Walewski, MD PhD, Robert W. Chen, MD, Rod Ramchandren, MD, Pier Luigi Zinzani, MD, David Cunningham, MD FRCP, Dae Seog Heo, MD, Andras Rosta, MD, Neil Josephson, MD, Katherine L. Ruffner, MD, Jessica Sachs, Rachael Liu, PhD, Hina Jolin, Pharm D, Dirk Huebner, MD, John A. Radford, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 6.
https://doi.org/10.1182/blood.V130.Suppl_1.6.6
Published: 2017
Journal Articles

New mutation in hairy cell leukemia

Tadeusz Robak, Piotr Smolewski
Journal: Blood
Blood (2015) 126 (8): 930–931.
https://doi.org/10.1182/blood-2015-06-652065
Published: 2015
Journal Articles

Novel target to kill CLL

Tadeusz Robak, Piotr Smolewski
Journal: Blood
Blood (2015) 125 (2): 211–212.
https://doi.org/10.1182/blood-2014-10-606582
Published: 2015
Journal Articles

Expression of Smad Proteins as a Potential Prognostic Factor in Chronic Lymphocytic Leukemia

Magdalena Witkowska, MD, Barbara Cebula-Obrzut, PhD, Agata Majchrzak, PhD, Aleksandra Medra, PhD, Tadeusz Robak, Prof, Piotr Smolewski, Prof
Journal: Blood
Blood (2014) 124 (21): 1957.
https://doi.org/10.1182/blood.V124.21.1957.1957
Published: 2014
Journal Articles

A Randomized, Multicenter Study (PALG CLL4/ ML 21283) Of Maintenance Treatment With Rituximab Versus Observation After Induction Treatment With Rituximab, Cladribine, and Cyclophosphamide (RCC) Regimen In Patients With Progressive Chronic Lymphocytic Leukemia: Interim Analysis

Tadeusz Robak, Jerzy Z. Blonski, MD, PhD, Krzysztof Jamroziak, MD, PhD, Aleksander Skotnicki, Professor, Magdalena Piotrowska, MD, Anatoly Uss, Professor, Janusz Kloczko, Professor, Jaroslaw Piszcz, Kazimierz Kuliczkowski, Professor, Tomasz Wrobel, MD PhD, Bozena Katarzyna Budziszewska, MD, PhD, Marta Fidecka, Piotr Smolewski, Professor
Journal: Blood
Blood (2013) 122 (21): 1640.
https://doi.org/10.1182/blood.V122.21.1640.1640
Published: 2013
Journal Articles

Diverse Impact of Notch-1, Jagged-1 and Dll-1 Expression On Response to Treatment and Relapse Free Survival in Acute Myeloid Leukemia.

Magdalena Czemerska, MD, Agnieszka Pluta, MD, PhD, Anna Szmigielska-Kaplon, MD, PhD, Ewa Wawrzyniak, PhD, Barbara Cebula-Obrzut, PhD, Aleksandra Medra, Piotr Smolewski, MD, PhD, Tadeusz Robak, MD, PhD, Agnieszka Wierzbowska, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2520.
https://doi.org/10.1182/blood.V120.21.2520.2520
Published: 2012
Journal Articles

Kinetics and Apoptotic Profile of Circulating Endothelial Cells In Patients Undergoing Autologous Stem Cell Transplantation

Anna Szmigielska-Kaplon, MD, PhD, Krawczynska Anna, MS, PhD, Czemerska Magdalena, MD, Agnieszka Pluta, MD, PhD, Barbara Cebula-Obrzut, MS, PhD, Anna Wolska, MD, Olga Grzybowska-Izydorczyk, MD, PhD, Piotr Smolewski, Tadeusz Robak, MD, PhD, Agnieszka Wierzbowska, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2961.
https://doi.org/10.1182/blood.V118.21.2961.2961
Published: 2011
Journal Articles

Pro-Apoptotic Effect of An Anti-CD37 Scfv-Fc Fusion Protein, in Combination with the Anti-CD20 Antibody, Ofatumumab, on Tumor Cells From B-Cell Malignancies

Piotr Smolewski, Robak Pawel, Barbara Cebula-Obrzut, Malgorzata Misiewicz, Aleksandra Jeske, Agata Majchrzak, Scott Stromatt, MD, Tadeusz Robak
Journal: Blood
Blood (2011) 118 (21): 1662.
https://doi.org/10.1182/blood.V118.21.1662.1662
Published: 2011
Journal Articles

Pro-Apoptotic Activity of Honokiol Analogues in B-Cell Lymphoid Malignancies

Piotr Smolewski, Aleksandra Jeske, Agata Majchrzak, Barbara Cebula, Michael Y Bonner, Jack L Arbiser, Tadeusz Robak
Journal: Blood
Blood (2011) 118 (21): 1663.
https://doi.org/10.1182/blood.V118.21.1663.1663
Published: 2011
Journal Articles

The Prognostic Role of Jagged-1 Protein Expression In Acute Myeloid Leukemia Patients

Agnieszka Wierzbowska, MD, PhD, Agnieszka Pluta, MD, PhD, Konrad Stepka, MD, Magdalena Czemerska, MD, Barbara Cebula-Obrzut, PhD, Anna Krawczynska, PhD, Olga Grzybowska-Izydorczyk, MD, PhD, Piotr Smolewski, MD, PhD, Tadeusz Robak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2726.
https://doi.org/10.1182/blood.V116.21.2726.2726
Published: 2010
Journal Articles

The Role of Inhibitor of Apoptosis Proteins Family Expression In Acute Myeloid Leukemia Patients

Agnieszka Pluta, MD, PhD, Agata Wrzesien-Kus, MD, PhD, Barbara Cebula-Obrzut, PhD, Konrad Stepka, MD, Anna Wolska, MD, Olga Grzybowska-Izydorczyk, MD, PhD, Magdalena Czemerska, MD, Piotr Smolewski, MD, PhD, Tadeusz Robak, MD, PhD, Agnieszka Wierzbowska, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2728.
https://doi.org/10.1182/blood.V116.21.2728.2728
Published: 2010
Journal Articles

Antitumor Activity of Amphibian Ribonucleases, Onconase and R-Amhinase, on Tumor Cells From B-Cell Lymphoproliferative Disorders

Piotr Smolewski, Malgorzata Zwoliñska, Barbara Cebula-Obrzut, Agata Majchrzak, Malgorzata Misiewicz, Aleksandra Jeske, Zbigniew Darzynkiewicz, Wojciech Ardelt, Barbara Ardelt, Shailendra K Saxena, Charles Muniz, Tadeusz Robak
Journal: Blood
Blood (2010) 116 (21): 2842.
https://doi.org/10.1182/blood.V116.21.2842.2842
Published: 2010
Journal Articles

The Prognostic Role of Smac/DIABLO Protein Expression in Acute Myeloid Leukemia.

Agnieszka Pluta, Agata Wrzesien-Kus, Barbara Cebula, Anna Wolska, Anna Szmigielska-Kaplon, Magdalena Czemerska, Piotr Smolewski, Tadeusz Robak, Agnieszka Wierzbowska
Journal: Blood
Blood (2009) 114 (22): 2626.
https://doi.org/10.1182/blood.V114.22.2626.2626
Published: 2009
Journal Articles

Activity of Anti-Tumor Endoribonucleases, Onconase (ranpirnase) and R-Amphinase in Chronic Lymphocytic Leukemia

Piotr Smolewski, Anna Linke-Szewczyk, Barbara Cebula, Kuslima Shogen, Wojciech Ardelt, Zbigniew Darzynkiewicz, Tadeusz Robak, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4205.
https://doi.org/10.1182/blood.V112.11.4205.4205
Published: 2008
Journal Articles

Ex Vivo Cytotoxic Activity of Endoribonucleases, Onconase (ranpirnase) and R-Amphinase, against Acute Myeloblastic Leukemia Cells

Piotr Smolewski, Barbara Cebula, Malgorzata Zwolinska, Anna Linke-Szewczyk, Dominika Wozniak, Kuslima Shogen, Wojciech Ardelt, Zbigniew Darzynkiewicz, Tadeusz Robak, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4010.
https://doi.org/10.1182/blood.V112.11.4010.4010
Published: 2008